These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8893849)

  • 41. Morpholine-based RGD-cyclopentapeptides as alphavbeta3/alphavbeta5 integrin ligands: role of configuration towards receptor binding affinity.
    Cini N; Trabocchi A; Menchi G; Bottoncetti A; Raspanti S; Pupi A; Guarna A
    Bioorg Med Chem; 2009 Feb; 17(4):1542-9. PubMed ID: 19195898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of conformation on the conversion of cyclo-(1,7)-Gly-Arg-Gly-Asp-Ser-Pro-Asp-Gly-OH to its cyclic imide degradation product.
    Bogdanowich-Knipp SJ; Jois SD; Siahaan TJ
    J Pept Res; 1999 Jul; 54(1):43-53. PubMed ID: 10448969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The aqueous conformation of cyclo(1,6)Ac-Cys-Arg-Gly-Asp-Phe-Pen-NH2.
    Siahaan TJ; Bruss D; Powell NA; Chakrabarti S; Conrad M
    Int J Pept Protein Res; 1994 Nov; 44(5):427-34. PubMed ID: 7896500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interpretation of 1H-NMR spectra of the cyclic analog of kallidin in solutions].
    Saulitis IuB; Liepin'sh EE; Mutulis FK; Chipens GI
    Bioorg Khim; 1986 Oct; 12(10):1317-28. PubMed ID: 3814184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-Methylated cyclic RGD peptides as highly active and selective alpha(V)beta(3) integrin antagonists.
    Dechantsreiter MA; Planker E; Mathä B; Lohof E; Hölzemann G; Jonczyk A; Goodman SL; Kessler H
    J Med Chem; 1999 Aug; 42(16):3033-40. PubMed ID: 10447947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple solution conformations of the integrin-binding cyclic pentapeptide cyclo(-Ser-D-Leu-Asp-Val-Pro-). Analysis of the (phi, psi) space available to cyclic pentapeptides.
    Viles JH; Mitchell JB; Gough SL; Doyle PM; Harris CJ; Sadler PJ; Thornton JM
    Eur J Biochem; 1996 Dec; 242(2):352-62. PubMed ID: 8973654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conformations and pharmacophores of cyclic RGD containing peptides which selectively bind integrin alpha(v)beta3.
    Locardi E; Mullen DG; Mattern RH; Goodman M
    J Pept Sci; 1999 Nov; 5(11):491-506. PubMed ID: 10587313
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conformation of cyclo-(L-threonine)2 and cyclo-(L-allothreonine)2. A proton and carbon n.m.r study.
    Kopple KD; Narutis V
    Int J Pept Protein Res; 1981 Jul; 18(1):33-40. PubMed ID: 6273344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The square conformation of phenylglycine-incorporated ascidiacyclamide is stabilized by CH/π interactions between amino acid side chains.
    Asano A; Yamada T; Doi M
    Bioorg Med Chem; 2011 Jun; 19(11):3372-7. PubMed ID: 21592800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A 1H-NMR study of the solution conformation of cyclo(GRGDSPA): conformational effects on the physiological activity.
    Mizutani R; Shimada I; Ueno Y; Yoda M; Kumagai H; Arata Y
    Biochem Biophys Res Commun; 1992 Jan; 182(2):966-73. PubMed ID: 1734894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Solution conformation and hydrolytic activity of cyclo(D-leu-L-his).
    Tanihara M; Imanishi Y; Higashimura T
    Biopolymers; 1977 Oct; 16(10):2217-29. PubMed ID: 911998
    [No Abstract]   [Full Text] [Related]  

  • 52. Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions.
    Leduc AM; Trent JO; Wittliff JL; Bramlett KS; Briggs SL; Chirgadze NY; Wang Y; Burris TP; Spatola AF
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11273-8. PubMed ID: 13679575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformation of cyclo-(D-phenylalanyl-trans-4-fluoro-D-prolyl).
    Ciarkowski J; Gdaniec M; Kołodziejczyk A; Liberek B; Borremans FA; Anteunis MJ
    Int J Pept Protein Res; 1990 Sep; 36(3):285-91. PubMed ID: 2279851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beta-turns in bridged proline-containing cyclic peptide models.
    Hollósi M; Kövér KE; Holly S; Radics L; Fasman GD
    Biopolymers; 1987 Sep; 26(9):1555-72. PubMed ID: 3663873
    [No Abstract]   [Full Text] [Related]  

  • 55. Peptides constrained by an aliphatic linkage between two C(alpha) sites: design, synthesis, and unexpected conformational properties of an i,(i + 4)-linked peptide.
    Alexander McNamara LM; Andrews MJ; Mitzel F; Siligardi G; Tabor AB
    J Org Chem; 2001 Jun; 66(13):4585-94. PubMed ID: 11421778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solution structure of regioselectively addressable functionalized templates: an NMR and restrained molecular dynamics investigation.
    Dumy P; Eggleston IM; Esposito G; Nicula S; Mutter M
    Biopolymers; 1996 Sep; 39(3):297-308. PubMed ID: 8756511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bicyclic peptides as type I/type II beta-turn scaffolds.
    Lombardi A; D'Auria G; Saviano M; Maglio O; Nastri F; Quartara L; Pedone C; Pavone V
    Biopolymers; 1996; 40(5):505-18. PubMed ID: 9062073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1H- and 13C-NMR. Studies of the molecular conformations of cyclo-tetraglycyl.
    Grathwohl C; Tun-Kyi A; Bundi A; Schwyzer R; Wüthrich K
    Helv Chim Acta; 1975 Mar; 58(2):415-23. PubMed ID: 1158722
    [No Abstract]   [Full Text] [Related]  

  • 59. Conformational energy and circular dichroism computed for cyclo-(pro-gly)3.
    Madison V
    Biopolymers; 1973; 12(8):1837-52. PubMed ID: 4733711
    [No Abstract]   [Full Text] [Related]  

  • 60. [Synthesis of cyclic analogues of the nerve growth factor loop 4].
    Morozova AA; Sumbatian NV; Lezina VP; Akparov VKh; Korshunova GA; Gudasheva TA
    Bioorg Khim; 2008; 34(5):617-29. PubMed ID: 19060936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.